tirzepatide approved for sleep apnea The FDA has just Zepbound (tirzepatide), the first medication designed to treat both obstructive apnoea (OSA) and obesity simultaneously. In clinical trials, Zepbound helped reduce breathing disruptions by 50% and Can Zepbound Treat Sleep Apnea?

They can guide you through everyday challenges such as emotional eating, meal planning, dining out, and portion control

The above findings underscore the potential of GLP-1R agonists as efficacious and safe drugs with pleiotropic activities on cardiovascular system that are independent of their glycemic control effects emphasizing cardiovascular outcomes as one of the primary goals in the management of type 2 diabetes

You must ensure there are at least two days (48 hours) between your last dose and your new dose

Seek urgent medical attention (call 999 or attend A&E) if you experience: Difficulty breathing or swallowing Swelling of the face, lips, tongue, or throat (angioedema) Widespread urticaria accompanied by dizziness, rapid pulse, or feeling faint Severe chest tightness or wheezing Blistering, peeling skin, or mucosal involvement (mouth, eyes, genitals) These symptoms may indicate anaphylaxis or a severe hypersensitivity reaction requiring immediate emergency treatment with adrenaline and supportive care